Bausch + Lomb has selected Steriline to strengthen its production of sterile ophthalmic medical devices, with the installation of the OFCM84 filling and capping line at Bausch + Lomb Italia.
Designed for aseptic processing and fully aligned with the latest EU GMP Annex 1 requirements, the new high-performance line enables the company to increase production capacity while reducing the risk of microbial, particulate, and endotoxin/pyrogen contamination in eye-care products.
Installed at Bausch + Lomb’s Italian manufacturing operations near Milan, the OFCM84 line delivers a production speed of up to 200 units per minute and integrates automated CIP and SIP processes. Its compact, servo-driven design — equipped with eight ceramic volumetric filling pumps — avoids rotating components, reducing potential contamination sources while maintaining stable laminar airflow conditions required for Grade A environments.
The system was selected not only for its technical performance but also for its clean design, operational simplicity, and ease of format changeover. According to Bausch + Lomb’s operations team, the intuitive operator interface and efficient CIP-SIP processes contribute to faster execution times compared with lines not originally designed for aseptic processing.
Following this successful implementation, Bausch + Lomb has already confirmed its confidence in Steriline’s technology by ordering two additional filling lines for its U.S. manufacturing sites in Tampa, Florida, and Greenville, South Carolina.
This project highlights the increasing demand for advanced aseptic solutions as ophthalmic therapies continue to expand globally.